Muhammad Yasir
Research Subjects
Muhammad Yasir has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Christos Papageorgiou
Dartmouth Cancer Center 1 Lebanon, New Hampshire
18 shared publications - Kristyn Conrad
Bond Life Sciences Center, University of Missouri
18 shared publications - Linda T. Vahdat
Department of Medicine, Dartmouth Cancer Center, Lebanon, NH, USA
18 shared publications - Michael Petris
Departments of Biochemistry and Ophthalmology, Bond Life Sciences Center, University of Missouri
18 shared publications - Nikita S. Gudekar
UNIVERSITY OF MISSOURI 2
18 shared publications - Parshad Suthar
UNIVERSITY OF MISSOURI 2
18 shared publications
Latest Publications
- Open Access
- 30 June 2026
- Published by American Association for Cancer Research (AACR)
Table 3 from Tumor CTR1 Expression and Systemic Copper Dynamics Converge on a Copper Axis in High-Grade Triple-Negative Breast Cancer
ΔCu levels in patients with breast cancer by molecular subtype (N = 21).
- 30 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable 3 from Tumor CTR1 Expression and Systemic Copper Dynamics Converge on a Copper Axis in High-Grade Triple-Negative Breast Cancer
ΔCu levels in patients with breast cancer by molecular subtype (N = 21).
- Open Access
- 30 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S1 from Tumor CTR1 Expression and Systemic Copper Dynamics Converge on a Copper Axis in High-Grade Triple-Negative Breast Cancer
Baseline ceruloplasmin activity was measured across breast cancer molecular subtypes and healthy volunteers.
- 30 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Tumor CTR1 Expression and Systemic Copper Dynamics Converge on a Copper Axis in High-Grade Triple-Negative Breast Cancer
Baseline ceruloplasmin activity was measured across breast cancer molecular subtypes and healthy volunteers.
- Open Access
- 30 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S2 from Tumor CTR1 Expression and Systemic Copper Dynamics Converge on a Copper Axis in High-Grade Triple-Negative Breast Cancer
This figure shows the relationship between baseline serum copper concentration and ceruloplasmin activity across breast cancer subtypes and healthy volunteers.
- 30 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Tumor CTR1 Expression and Systemic Copper Dynamics Converge on a Copper Axis in High-Grade Triple-Negative Breast Cancer
This figure shows the relationship between baseline serum copper concentration and ceruloplasmin activity across breast cancer subtypes and healthy volunteers.
- Open Access
- 30 June 2026
- Published by American Association for Cancer Research (AACR)
Figure 6 from Tumor CTR1 Expression and Systemic Copper Dynamics Converge on a Copper Axis in High-Grade Triple-Negative Breast Cancer
Serum Cu levels by clinical T stage. Box plots show serum Cu concentrations (μg/kg) for patients with stage T1 (n = 3) and stages T2–T3 (n = 16) breast tumors. The horizontal line within each box indicates the median, box edges represent the IQR, and whiskers denote the minimum and maximum values.
- 30 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 6 from Tumor CTR1 Expression and Systemic Copper Dynamics Converge on a Copper Axis in High-Grade Triple-Negative Breast Cancer
Serum Cu levels by clinical T stage. Box plots show serum Cu concentrations (μg/kg) for patients with stage T1 (n = 3) and stages T2–T3 (n = 16) breast tumors. The horizontal line within each box indicates the median, box edges represent the IQR, and whiskers denote the minimum and maximum values.
- Open Access
- 30 June 2026
- Published by American Association for Cancer Research (AACR)
Table 1 from Tumor CTR1 Expression and Systemic Copper Dynamics Converge on a Copper Axis in High-Grade Triple-Negative Breast Cancer
Demographic and clinical characteristics of patients with breast cancer (N = 21).
- 30 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable 1 from Tumor CTR1 Expression and Systemic Copper Dynamics Converge on a Copper Axis in High-Grade Triple-Negative Breast Cancer
Demographic and clinical characteristics of patients with breast cancer (N = 21).
- Open Access
- 30 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from Tumor CTR1 Expression and Systemic Copper Dynamics Converge on a Copper Axis in High-Grade Triple-Negative Breast Cancer
This figure compares therapy-associated changes in serum copper and ceruloplasmin activity across breast cancer molecular subtypes.
- 30 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Tumor CTR1 Expression and Systemic Copper Dynamics Converge on a Copper Axis in High-Grade Triple-Negative Breast Cancer
This figure compares therapy-associated changes in serum copper and ceruloplasmin activity across breast cancer molecular subtypes.
- Open Access
- 30 June 2026
- Published by American Association for Cancer Research (AACR)
Table 2 from Tumor CTR1 Expression and Systemic Copper Dynamics Converge on a Copper Axis in High-Grade Triple-Negative Breast Cancer
Sample distribution and statistical comparison for SLC31A1 analysis across breast cancer subtypes.
- 30 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable 2 from Tumor CTR1 Expression and Systemic Copper Dynamics Converge on a Copper Axis in High-Grade Triple-Negative Breast Cancer
Sample distribution and statistical comparison for SLC31A1 analysis across breast cancer subtypes.
- Open Access
- 30 June 2026
- Published by American Association for Cancer Research (AACR)
Table S2 from Tumor CTR1 Expression and Systemic Copper Dynamics Converge on a Copper Axis in High-Grade Triple-Negative Breast Cancer
This table lists therapy-associated changes in serum copper and ceruloplasmin activity for breast cancer patients grouped by molecular subtype.
- 30 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from Tumor CTR1 Expression and Systemic Copper Dynamics Converge on a Copper Axis in High-Grade Triple-Negative Breast Cancer
This table lists therapy-associated changes in serum copper and ceruloplasmin activity for breast cancer patients grouped by molecular subtype.
- Open Access
- 30 June 2026
- Published by American Association for Cancer Research (AACR)
Figure 2 from Tumor CTR1 Expression and Systemic Copper Dynamics Converge on a Copper Axis in High-Grade Triple-Negative Breast Cancer
CTR1 protein function and SLC31A1 expression by pathologic response. A, Illustration of CTR1 on the tumor cell surface mediating Cu uptake. B–D, Baseline tumor SLC31A1 transcript levels stratified by subsequent pathologic response across luminal A, luminal B, and TNBC. E and F,SLC31A1 expression in grade 2 and grade 3 TNBCs stratified by pathologic response. ns, not significant.
- 30 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 2 from Tumor CTR1 Expression and Systemic Copper Dynamics Converge on a Copper Axis in High-Grade Triple-Negative Breast Cancer
CTR1 protein function and SLC31A1 expression by pathologic response. A, Illustration of CTR1 on the tumor cell surface mediating Cu uptake. B–D, Baseline tumor SLC31A1 transcript levels stratified by subsequent pathologic response across luminal A, luminal B, and TNBC. E and F,SLC31A1 expression in grade 2 and grade 3 TNBCs stratified by pathologic response. ns, not significant.
- Open Access
- 30 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from Tumor CTR1 Expression and Systemic Copper Dynamics Converge on a Copper Axis in High-Grade Triple-Negative Breast Cancer
This figure shows pan-cancer SLC31A1 expression in tumor versus normal tissues using TCGA data accessed through GEPIA.
- 30 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Tumor CTR1 Expression and Systemic Copper Dynamics Converge on a Copper Axis in High-Grade Triple-Negative Breast Cancer
This figure shows pan-cancer SLC31A1 expression in tumor versus normal tissues using TCGA data accessed through GEPIA.